Lincoln Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Lincoln Pharmaceuticals has a total shareholder equity of ₹5.9B and total debt of ₹10.7M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹7.0B and ₹1.1B respectively. Lincoln Pharmaceuticals's EBIT is ₹906.2M making its interest coverage ratio 60.9. It has cash and short-term investments of ₹1.5B.
Key information
0.2%
Debt to equity ratio
₹10.67m
Debt
| Interest coverage ratio | 60.9x |
| Cash | ₹1.53b |
| Equity | ₹5.93b |
| Total liabilities | ₹1.07b |
| Total assets | ₹7.00b |
Recent financial health updates
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Recent updates
Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?
Sep 06Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Financial Position Analysis
Short Term Liabilities: LINCOLN's short term assets (₹4.5B) exceed its short term liabilities (₹922.8M).
Long Term Liabilities: LINCOLN's short term assets (₹4.5B) exceed its long term liabilities (₹151.8M).
Debt to Equity History and Analysis
Debt Level: LINCOLN has more cash than its total debt.
Reducing Debt: LINCOLN's debt to equity ratio has reduced from 11.8% to 0.2% over the past 5 years.
Debt Coverage: LINCOLN's debt is well covered by operating cash flow (5925.9%).
Interest Coverage: LINCOLN's interest payments on its debt are well covered by EBIT (60.9x coverage).